Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT03539575
NA
CB1R in Synthetic Psychoactive Cannabinoids
Sponsor: Yale University
View on ClinicalTrials.gov
Summary
The purpose of this research study is to determine whether the CB1R availability is lower in synthetic psychoactive cannabinoid subjects using the most widely available synthetic psychoactive cannabinoids at the time the study is initiated.
Official title: CB1R Availability in Synthetic Psychoactive Cannabinoid Users
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2018-05-01
Completion Date
2025-12
Last Updated
2025-04-10
Healthy Volunteers
Yes
Conditions
Interventions
OTHER
[11-C]OMAR
The radiotracer, \[11-C\]OMAR will be administered at no more than 10 micrograms at the beginning of each PET scan.
Locations (1)
Connecticut Mental Health Center
New Haven, Connecticut, United States